Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

2006

November-December 2006 edition

  • 2006 Practice Guidelines for the Diagnosis and Management of Cough
  • Guidelines for the Treatment of Sexually Transmitted Diseases
  • P & T Committee Formulary Action

September-October 2006 edition

  • Emergency Contraception
  • Clopidogrel Desensitization
  • Fondaparinux for Heparin-induced Thrombocytopenia

July-August 2006 edition

  • Safety of long acting beta2-adrenergic agonists
  • Tigecycline
  • FDA warning regarding filling prescriptions abroad
  • P&T Committee Formulary Action

May-June 2006 edition

  • Contrast Media and Nephrotoxicity
  • Pertussis Vaccine in Adolescents and Adults
  • Herpes Zoster Vaccine (Zostavax)
  • Human Papillomavirus Vaccine
  • Update on Mumps
  • P&T Committee Formulary Action

March-April 2006 edition

  • Managing Antibiotic Resistance in Gram-Negative Pathogens
  • Clostridium difficile and Rising Rates
  • New Recommendations on the Use of Amantadine and Rimantadine for Influenza A
  • P&T Committee Formulary Action

January-February 2006 edition

  • Statins and Cancer Risk
  • Aromatase Inhibitors
  • Bisphosphonates and Jaw Osteonecrosis
  • Medical Literature: Fact or Fiction
  • Nimodipine Box Warning about Medication Administration Error
  • P&T Committee Formulary Action
Top